Search for a doctor

Susan L. Samson, M.D., Ph.D.

  1. Endocrinologist
Request an Appointment

Publications

  1. Sanchez-Garavito JE, Perez-Vega C, Iyer H, Rios-Zermeno J, Martinez GN, Navarro Garcia de Llano JP, Chang AY, Donaldson AM, Olomu OU, Chaichana KL, Quinones-Hinojosa A, Almeida JP, Samson SL. Implementation of a Standardized Interdisciplinary Perioperative Protocol for Patients Undergoing Transsphenoidal Surgery: Impact on Patient Outcomes. World Neurosurg. 2024 Jul 30 Epub 2024 July 30
    View PubMed
  2. Fleseriu M, Nachtigall LB, Samson SL, Melmed S. Oral octreotide capsules for acromegaly treatment: application of clinical trial insights to real-world use. Expert Rev Endocrinol Metab. 2024 Jul; 19 (4):367-375 Epub 2024 June 06
    View PubMed
  3. Samson SL, Feldt-Rasmussen U, Zhang SL, Yu Y, Witek P, Kalra P, Bolanowski M. Managing high blood sugar (hyperglycaemia) during pasireotide treatment: A plain language summary of the B2219 study Future Rare Diseases. 2024; 4(1).
  4. Alvarez Caicedo DC, Donaldson AM, Samson SL, Chaichana KL, Almeida JP. Endoscopic Endonasal Transcavernous Hemipituitary Transposition for Resection of Invasive Prolactinoma: 2-Dimensional Operative Video. Oper Neurosurg (Hagerstown). 2024 Feb 1 Epub 2024 Feb 01
    View PubMed
  5. Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C, van der Lely AJ, Wass J, Melmed S, Acromegaly Consensus Group. Consensus on criteria for acromegaly diagnosis and remission. Pituitary. 2024 Feb; 27(1):7-22. Epub 2023 Nov 03.
    View PubMed
  6. Feldt-Rasmussen U, Bolanowski M, Zhang SL, Yu Y, Witek P, Kalra P, Kietsiriroje N, Piacentini A, Pedroncelli AM, Samson SL. Predictive factors and the management of hyperglycemia in patients with acromegaly and Cushing's disease receiving pasireotide treatment: post hoc analyses from the SOM230B2219 study. Front Endocrinol (Lausanne). 2024; 15:1250822 Epub 2024 Mar 21
    View PubMed
  7. Petersenn S, Fleseriu M, Casanueva FF, Giustina A, Biermasz N, Biller BMK, Bronstein M, Chanson P, Fukuoka H, Gadelha M, Greenman Y, Gurnell M, Ho KKY, Honegger J, Ioachimescu AG, Kaiser UB, Karavitaki N, Katznelson L, Lodish M, Maiter D, Marcus HJ, McCormack A, Molitch M, Muir CA, Neggers S, Pereira AM, Pivonello R, Post K, Raverot G, Salvatori R, Samson SL, Shimon I, Spencer-Segal J, Vila G, Wass J, Melmed S. Author Correction: Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Rev Endocrinol. 2024 Jan; 20 (1):62
    View PubMed
  8. Hong S, Shinya Y, Trejo-Lopez JA, Gruber LM, Erickson D, Bendok BR, Chaichana KL, Atkinson JL, Marino MJ, Donaldson AM, Stokken JK, Westphal SA, Chang AY, Samson SL, Choby GW, Van Gompel JJ. The clinical presentation of PIT1 positive pituitary neuroendocrine tumor immunonegative for growth hormone, prolactin, and thyroid stimulating hormone with analysis of clinical and immunostaining dissociation. Clin Neurol Neurosurg. 2024 Jan; 236:108075 Epub 2023 Nov 30
    View PubMed
  9. Petersenn S, Fleseriu M, Casanueva FF, Giustina A, Biermasz N, Biller BMK, Bronstein M, Chanson P, Fukuoka H, Gadelha M, Greenman Y, Gurnell M, Ho KKY, Honegger J, Ioachimescu AG, Kaiser UB, Karavitaki N, Katznelson L, Lodish M, Maiter D, Marcus HJ, McCormack A, Molitch M, Muir CA, Neggers S, Pereira AM, Pivonello R, Post K, Raverot G, Salvatori R, Samson SL, Shimon I, Spencer-Segal J, Vila G, Wass J, Melmed S. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Rev Endocrinol. 2023 Dec; 19 (12):722-740 Epub 2023 Sept 05
    View PubMed
  10. Snyder R, Lee S, Athukuri P, Tan EM, Fox MG, Fakhri S, Takashima M, Force BK, Samson SL, Gallagher KK, Yoshor D, Jalali A. Epidural Interlay Graft for Pituitary Surgery: A 4-Year Institutional Experience Journal of Neurological Surgery Part B: Skull Base. 2023.
  11. Vaughan EM, Virani S, Al Rifai M, Cardenas VJ Jr, Johnston CA, Porterfield L, Santiago Delgado Z, Samson SL, Schick V, Naik AD. Determining call-to-entry rate and recruitment barriers in clinical studies for community clinics serving low-income populations: a cohort study. BMJ Open. 2023 Oct 28; 13 (10):e077819
    View PubMed
  12. McKevitt C, Gabriel E, Marenco-Hillembrand L, Otamendi-Lopez A, Jeevaratnam S, Almeida JP, Samson S, Chaichana KL. Supervised machine learning to validate a novel scoring system for the prediction of disease remission of functional pituitary adenomas following transsphenoidal surgery. Sci Rep. 2023 Sep 16; 13 (1):15409 Epub 2023 Sept 16
    View PubMed
  13. Figueredo LF, Martínez AL, Suarez-Meade P, Marenco-Hillembrand L, Salazar AF, Pabon D, Guzmán J, Murguiondo-Perez R, Hallak H, Godo A, Sandoval-Garcia C, Ordoñez-Rubiano EG, Donaldson A, Chaichana KL, Peris-Celda M, Bendok BR, Samson SL, Quinones-Hinojosa A, Almeida JP. Current Role of Endoscopic Endonasal Approach for Craniopharyngiomas: A 10-Year Systematic Review and Meta-Analysis Comparison with the Open Transcranial Approach. Brain Sci. 2023 May 23; 13(6).
    View PubMed
  14. Samson SL, Vellanki P, Blonde L, Christofides EA, Galindo RJ, Hirsch IB, Isaacs SD, Izuora KE, Low Wang CC, Twining CL, Umpierrez GE, Valencia WM. American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm - 2023 Update. Endocr Pract. 2023 May; 29 (5):305-340
    View PubMed
  15. Rech MM, de Macedo Filho L, White AJ, Perez-Vega C, Samson SL, Chaichana KL, Olomu OU, Quinones-Hinojosa A, Almeida JP. Machine Learning Models to Forecast Outcomes of Pituitary Surgery: A Systematic Review in Quality of Reporting and Current Evidence. Brain Sci. 2023 Mar 15; 13(3).
    View PubMed
  16. Asbun D, Cheng YL, Bush W, Samson SL, Meek S, Paz-Fumagalli R, Lewis A, Gabriel E, Asbun H, Rao SN, Elli EF. Eleven-Year Experience with Selective Adrenal Vein Sampling in Management of Primary Adrenal Hormonal Hypersecretion. J Laparoendosc Adv Surg Tech A. 2023 Feb; 33(2):129-136. Epub 2022 Nov 01.
    View PubMed
  17. Samson SL, Nachtigall LB, Fleseriu M, Jensterle M, Manning PJ, Elenkova A, Molitch ME, Ludlam WH, Patou G, Haviv A, Biermasz NR, Giustina A, Strasburger CJ, Kennedy L, Melmed S. Durable biochemical response and safety with oral octreotide capsules in acromegaly. Eur J Endocrinol. 2022 Dec 1; 187 (6):733-741 Epub 2022 Oct 26
    View PubMed
  18. Force BK, Staggers K, Sebastian S, Takashima M, Yoshor D, Samson SL. Endoscopic Endonasal Transsphenoidal Surgery for Patients with Prolactinomas: Indications and Outcomes. World Neurosurg. 2022 Dec; 168:e626-e635 Epub 2022 Oct 19
    View PubMed
  19. de Macêdo Filho LJM, Diógenes AVG, Barreto EG, Pahwa B, Samson SL, Chaichana K, Quinones-Hinojosa A, Almeida JP. Endoscopic Endonasal Resection of the Medial Wall of the Cavernous Sinus and Its Impact on Outcomes of Pituitary Surgery: A Systematic Review and Meta-Analysis. Brain Sci. 2022 Oct 06; 12(10).
    View PubMed
  20. Blonde L, Umpierrez GE, Reddy SS, McGill JB, Berga SL, Bush M, Chandrasekaran S, DeFronzo RA, Einhorn D, Galindo RJ, Gardner TW, Garg R, Garvey WT, Hirsch IB, Hurley DL, Izuora K, Kosiborod M, Olson D, Patel SB, Pop-Busui R, Sadhu AR, Samson SL, Stec C, Tamborlane WV Jr, Tuttle KR, Twining C, Vella A, Vellanki P, Weber SL. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. Endocr Pract. 2022 Oct; 28 (10):923-1049 Epub 2022 Aug 11
    View PubMed
  21. Yuen KCJ, Samson SL, Bancos I, Gosmanov AR, Jasim S, Fecher LA, Weber JS. American Association of Clinical Endocrinology Disease State Clinical Review: Evaluation and Management of Immune Checkpoint Inhibitor-Mediated Endocrinopathies: A Practical Case-Based Clinical Approach. Endocr Pract. 2022 Jul; 28 (7):719-731 Epub 2022 Apr 25
    View PubMed
  22. Yuen KCJ, Samson SL. Oral Octreotide: A Review of Recent Clinical Trials and Practical Recommendations for Its Use in the Treatment of Patients With Acromegaly. Endocr Pract. 2022 Jun; 28 (6):637-645 Epub 2022 Apr 19
    View PubMed
  23. Perez-Vega C, Ramos-Fresnedo A, Tripathi S, Domingo RA, Ravindran K, Almeida JP, Peterson J, Trifiletti DM, Chaichana KL, Quinones-Hinojosa A, Samson SL. Treatment of recurrent and persistent Cushing's disease after first transsphenoidal surgery: lessons learned from an international meta-analysis. Pituitary. 2022 Jun; 25(3):540-549. Epub 2022 May 04.
    View PubMed
  24. Zhang WQ, Glaun MD, Jalali A, Samson SL, Gallagher KK. Esthesioneuroblastoma as a cause of syndrome of inappropriate antidiuretic hormone ACTA OTO-LARYNGOLOGICA CASE REPORTS. 2022; 7(1):19-21. Epub 2022 Dec 01.
  25. Pradhan G, Lee JH, Wu CS, Wang H, Lin L, Donti T, Graham BH, Rajan AS, Balasubramanyam A, Samson SL, Guo S, Sun Y. Mechanistic Investigation of GHS-R Mediated Glucose-Stimulated Insulin Secretion in Pancreatic Islets. Biomolecules. 2022 Mar 6; 12 (3) Epub 2022 Mar 06
    View PubMed
  26. Labadzhyan A, Nachtigall LB, Fleseriu M, Gordon MB, Molitch M, Kennedy L, Samson SL, Greenman Y, Biermasz N, Bolanowski M, Haviv A, Ludlam W, Patou G, Strasburger CJ. Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results. Pituitary. 2021 Dec; 24 (6):943-953 Epub 2021 June 25
    View PubMed
  27. Labadzhyan A, Nachtigall LB, Fleseriu M, Gordon MB, Molitch M, Kennedy L, Samson SL, Greenman Y, Biermasz N, Bolanowski M, Haviv A, Ludlam W, Patou G, Strasburger CJ. Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results. Pituitary. 2021 Dec; 24 (6):954
    View PubMed
  28. Samson SL, Gu F, Feldt-Rasmussen U, Zhang S, Yu Y, Witek P, Kalra P, Pedroncelli AM, Pultar P, Jabbour N, Paul M, Bolanowski M. Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study. Pituitary. 2021 Dec; 24 (6):887-903 Epub 2021 July 18
    View PubMed
  29. Perez-Vega C, Tripathi S, Domingo RA, Ramos-Fresnedo A, Lee SJ, Chaichana KL, Quinones-Hinojosa A, Samson SL. Fluid Restriction After Transsphenoidal Surgery for the Prevention of Delayed Hyponatremia: A Systematic Review and Meta-Analysis. Endocr Pract. 2021 Sep; 27 (9):966-972 Epub 2021 July 13
    View PubMed
  30. Yuen KCJ, Alter CA, Miller BS, Gannon AW, Tritos NA, Samson SL, Dobri G, Kurtz K, Strobl F, Kelepouris N. Adult growth hormone deficiency: Optimizing transition of care from pediatric to adult services. Growth Horm IGF Res. 2021 Feb; 56:101375 Epub 2020 Dec 10
    View PubMed
  31. Fleseriu M, Biller BMK, Freda PU, Gadelha MR, Giustina A, Katznelson L, Molitch ME, Samson SL, Strasburger CJ, van der Lely AJ, Melmed S. A Pituitary Society update to acromegaly management guidelines. Pituitary. 2021 Feb; 24 (1):1-13 Epub 2020 Oct 20
    View PubMed
  32. Giustina A, Barkhoudarian G, Beckers A, Ben-Shlomo A, Biermasz N, Biller B, Boguszewski C, Bolanowski M, Bollerslev J, Bonert V, Bronstein MD, Buchfelder M, Casanueva F, Chanson P, Clemmons D, Fleseriu M, Formenti AM, Freda P, Gadelha M, Geer E, Gurnell M, Heaney AP, Ho KKY, Ioachimescu AG, Lamberts S, Laws E, Losa M, Maffei P, Mamelak A, Mercado M, Molitch M, Mortini P, Pereira AM, Petersenn S, Post K, Puig-Domingo M, Salvatori R, Samson SL, Shimon I, Strasburger C, Swearingen B, Trainer P, Vance ML, Wass J, Wierman ME, Yuen KCJ, Zatelli MC, Melmed S. Multidisciplinary management of acromegaly: A consensus. Rev Endocr Metab Disord. 2020 Dec; 21 (4):667-678 Epub 2020 Sept 10
    View PubMed
  33. Brown DR, East HE, Eilerman BS, Gordon MB, King EE, Knecht LA, Salke B, Samson SL, Yuen KCJ, Yau H. Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendations. Clin Diabetes Endocrinol. 2020 Oct 29; 6 (1):18
    View PubMed
  34. Samson SL, Nachtigall LB, Fleseriu M, Gordon MB, Bolanowski M, Labadzhyan A, Ur E, Molitch M, Ludlam WH, Patou G, Haviv A, Biermasz N, Giustina A, Trainer PJ, Strasburger CJ, Kennedy L, Melmed S. Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide. J Clin Endocrinol Metab. 2020 Oct 1; 105 (10)
    View PubMed
  35. Winograd D, Staggers KA, Sebastian S, Takashima M, Yoshor D, Samson SL. An Effective and Practical Fluid Restriction Protocol to Decrease the Risk of Hyponatremia and Readmissions After Transsphenoidal Surgery. Neurosurgery. 2020 Sep 15; 87 (4):761-769
    View PubMed
  36. Vaughan EM, Hyman DJ, Naik AD, Samson SL, Razjouyan J, Foreyt JP. A Telehealth-supported, Integrated care with CHWs, and MEdication-access (TIME) Program for Diabetes Improves HbA1c: a Randomized Clinical Trial. J Gen Intern Med. 2020 Jul 22 Epub 2020 July 22
    View PubMed
  37. Vaughan EM, Naik AD, Lewis CM, Foreyt JP, Samson SL, Hyman DJ. Telemedicine Training and Support for Community Health Workers: Improving Knowledge of Diabetes. Telemed J E Health. 2020 Feb; 26 (2):244-250 Epub 2019 Mar 06
    View PubMed
  38. Griffin DM, Bitner BR, Criss Ii Z, Marcano D, Berlin JM, Kent TA, Tour JM, Samson SL, Pautler RG. Use of a bioengineered antioxidant in mouse models of metabolic syndrome. Expert Opin Investig Drugs. 2020 Feb; 29 (2):209-219 Epub 2020 Jan 20
    View PubMed
  39. Garber AJ, Handelsman Y, Grunberger G, Einhorn D, Abrahamson MJ, Barzilay JI, Blonde L, Bush MA, DeFronzo RA, Garber JR, Garvey WT, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Perreault L, Rosenblit PD, Samson S, Umpierrez GE. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2020 EXECUTIVE SUMMARY. Endocr Pract. 2020 Jan; 26 (1):107-139
    View PubMed
  40. Vaughan EM, Rueda JJ, Samson SL, Hyman DJ. Reducing the Burden of Diabetes Treatment: A Review of Low-cost Oral Hypoglycemic Medications. Curr Diabetes Rev. 2020; 16 (8):851-858
    View PubMed
  41. Force BK, Vogel TP, Nguyen DM, Heck KA, Sebastian S, Takashima M, Yoshor D, Samson SL. A Remarkable Response of Granulomatous Hypophysitis to Infliximab in a Patient With a Background of Crohn's Disease-A Case Report. Front Endocrinol (Lausanne). 2020; 11:350 Epub 2020 May 29
    View PubMed
  42. Mechanick JI, Adams S, Davidson JA, Fergus IV, Galindo RJ, McKinney KH, Petak SM, Sadhu AR, Samson SL, Vedanthan R, Umpierrez GE. TRANSCULTURAL DIABETES CARE IN THE UNITED STATES - A POSITION STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS. Endocr Pract. 2019 Jul; 25 (7):729-765 Epub 2019 May 09
    View PubMed
  43. Casanueva FF, Barkan AL, Buchfelder M, Klibanski A, Laws ER, Loeffler JS, Melmed S, Mortini P, Wass J, Giustina A, Pituitary Society, Expert Group on Pituitary Tumors. Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement. Pituitary. 2017 Oct; 20 (5):489-498
    View PubMed
  44. Pradhan G, Wu CS, Han Lee J, Kanikarla P, Guo S, Yechoor VK, Samson SL, Sun Y. Obestatin stimulates glucose-induced insulin secretion through ghrelin receptor GHS-R. Sci Rep. 2017 Apr 20; 7 (1):979
    View PubMed
  45. Fleseriu M, Hamrahian AH, Hoffman AR, Kelly DF, Katznelson L, AACE Neuroendocrine and Pituitary Scientific Committee *. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: DIAGNOSIS OF RECURRENCE IN CUSHING DISEASE. Endocr Pract. 2016 Dec; 22 (12):1436-1448 Epub 2016 Sept 19
    View PubMed
  46. Samson SL, Garber AJ. A Plethora of GLP-1 Agonists: Decisions About What to Use and When. Curr Diab Rep. 2016 Dec; 16 (12):120
    View PubMed
  47. Yuen KC, Tritos NA, Samson SL, Hoffman AR, Katznelson L. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: UPDATE ON GROWTH HORMONE STIMULATION TESTING AND PROPOSED REVISED CUT-POINT FOR THE GLUCAGON STIMULATION TEST IN THE DIAGNOSIS OF ADULT GROWTH HORMONE DEFICIENCY. Endocr Pract. 2016 Oct; 22 (10):1235-1244 Epub 2016 July 13
    View PubMed
  48. Samson SL. Management of Hyperglycemia in Patients With Acromegaly Treated With Pasireotide LAR. Drugs. 2016 Sep; 76 (13):1235-1243
    View PubMed
  49. Bronstein MD, Fleseriu M, Neggers S, Colao A, Sheppard M, Gu F, Shen CC, Gadelha M, Farrall AJ, Hermosillo Resendiz K, Ruffin M, Chen Y, Freda P, Pasireotide C2305 Study Group. Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study. BMC Endocr Disord. 2016 Apr 2; 16:16 Epub 2016 Apr 02
    View PubMed
  50. Samson SL, Hamrahian AH, Ezzat S, AACE Neuroendocrine and Pituitary Scientific Committee//American College of Endocrinology (ACE). AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: CLINICAL RELEVANCE OF MACROPROLACTIN IN THE ABSENCE OR PRESENCE OF TRUE HYPERPROLACTINEMIA. Endocr Pract. 2015 Dec; 21 (12):1427-35
    View PubMed
  51. Li R, Buras E, Lee J, Liu R, Liu V, Espiritu C, Ozer K, Thompson B, Nally L, Yuan G, Oka K, Chang B, Samson S, Yechoor V, Chan L. Gene therapy with neurogenin3, betacellulin and SOCS1 reverses diabetes in NOD mice. Gene Ther. 2015 Nov; 22 (11):876-82 Epub 2015 July 14
    View PubMed
  52. Schopohl J, Gu F, Rubens R, Van Gaal L, Bertherat J, Ligueros-Saylan M, Trovato A, Hughes G, Salgado LR, Boscaro M, Pivonello R, Pasireotide B2305 Study Group. Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing's disease: results from an open-ended, open-label extension trial. Pituitary. 2015 Oct; 18(5):604-12.
    View PubMed
  53. Tritos NA, Yuen KC, Kelly DF, AACE Neuroendocrine and Pituitary Scientific Committee. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: A NEUROENDOCRINE APPROACH TO PATIENTS WITH TRAUMATIC BRAIN INJURY. Endocr Pract. 2015 Jul; 21 (7):823-31
    View PubMed
  54. Fleseriu M, Hoffman AR, Katznelson L, AACE Neuroendocrine and Pituitary Scientific Committee. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: MANAGEMENT OF ACROMEGALY PATIENTS: WHAT IS THE ROLE OF PRE-OPERATIVE MEDICAL THERAPY? Endocr Pract. 2015 Jun; 21 (6):668-73
    View PubMed
  55. Samson SL. Pasireotide in Acromegaly: An Overview of Current Mechanistic and Clinical Data. Neuroendocrinology. 2015; 102 (1-2):8-17 Epub 2015 Mar 16
    View PubMed
  56. Gelbke HP, Banton M, Leibold E, Pemberton M, Samson SL. A critical review finds styrene lacks direct endocrine disruptor activity. Crit Rev Toxicol. 2015; 45 (9):727-64 Epub 2015 Sept 25
    View PubMed
  57. Pivonello R, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Trovato A, Hughes G, Salgado LR, Lacroix A, Schopohl J, Biller BM, Pasireotide B2305 Study Group. Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study. Clin Endocrinol (Oxf). 2014 Sep; 81 (3):408-17 Epub 2014 Mar 27
    View PubMed
  58. Samson SL. Long-term medical treatment of cushing's disease with pasireotide: a review of current evidence and clinical experience. Exp Clin Endocrinol Diabetes. 2014 Sep; 122 (8):445-50 Epub 2014 July 08
    View PubMed
  59. Kim J, Samson SL. Cardiovascular effects of incretin therapy in diabetes care. Metab Syndr Relat Disord. 2014 Aug; 12 (6):303-10 Epub 2014 May 19
    View PubMed
  60. Hamrahian AH, Yuen KC, Hoffman AR, AACE Neuroendocrine And Pituitary Scientific Committee. AACE/ACE Disease State Clinical Review: Medical Management of Cushing Disease. Endocr Pract. 2014 Jul; 20 (7):746-57
    View PubMed
  61. Samson SL, Ezzat S. AACE/ACE Disease State Clinical Review: Dopamine Agonists for Hyperprolactinemia and the Risk of Cardiac Valve Disease. Endocr Pract. 2014 Jun; 20 (6):608-16
    View PubMed
  62. Colao A, Bronstein MD, Freda P, Gu F, Shen CC, Gadelha M, Fleseriu M, van der Lely AJ, Farrall AJ, Hermosillo Reséndiz K, Ruffin M, Chen Y, Sheppard M, Pasireotide C2305 Study Group. Pasireotide versus octreotide in acromegaly: a head-to-head superiority study. J Clin Endocrinol Metab. 2014 Mar; 99(3):791-9. Epub 2014 Jan 13.
    View PubMed
  63. Colao A, Bronstein MD, Freda P, Gu F, Shen CC, Gadelha M, Fleseriu M, van der Lely AJ, Farrall AJ, Hermosillo Resendiz K, Ruffin M, Chen Y, Sheppard M, Pasireotide C2305 Study Group. Pasireotide versus octreotide in acromegaly: a head-to-head superiority study. J Clin Endocrinol Metab. 2014 Mar; 99(3):791-9. Epub 2014 Jan 13.
    View PubMed
  64. Thomas JG, Gadgil N, Samson SL, Takashima M, Yoshor D. Prospective trial of a short hospital stay protocol after endoscopic endonasal pituitary adenoma surgery. World Neurosurg. 2014 Mar-Apr; 81 (3-4):576-83 Epub 2013 Nov 13
    View PubMed
  65. Samson SL, Garber AJ. Metabolic syndrome. Endocrinol Metab Clin North Am. 2014 Mar; 43 (1):1-23
    View PubMed
  66. Agarwal N, Iyer D, Patel SG, Sekhar RV, Phillips TM, Schubert U, Oplt T, Buras ED, Samson SL, Couturier J, Lewis DE, Rodriguez-Barradas MC, Jahoor F, Kino T, Kopp JB, Balasubramanyam A. HIV-1 Vpr induces adipose dysfunction in vivo through reciprocal effects on PPAR/GR co-regulation. Sci Transl Med. 2013 Nov 27; 5 (213):213ra164
    View PubMed
  67. Pradhan G, Samson SL, Sun Y. Ghrelin: much more than a hunger hormone. Curr Opin Clin Nutr Metab Care. 2013 Nov; 16 (6):619-24
    View PubMed
  68. Samson SL, Bajaj M. Potential of incretin-based therapies for non-alcoholic fatty liver disease. J Diabetes Complications. 2013 Jul-Aug; 27 (4):401-6 Epub 2013 Jan 24
    View PubMed
  69. Nguyen D, Samson SL, Reddy VT, Gonzalez EV, Sekhar RV. Impaired mitochondrial fatty acid oxidation and insulin resistance in aging: novel protective role of glutathione. Aging Cell. 2013 Jun; 12 (3):415-25 Epub 2013 Apr 19
    View PubMed
  70. Samson SL, Garber A. GLP-1R agonist therapy for diabetes: benefits and potential risks. Curr Opin Endocrinol Diabetes Obes. 2013 Apr; 20 (2):87-97
    View PubMed
  71. Samson SL, Bajaj M. Direct actions of GLP-1 analogues on AMP-activated protein kinase activity are distinct from cyclic AMP accumulation. J Hepatol 2013 Mar; 58 (3):634-5 Epub 2012 Nov 14
    View PubMed
  72. Colao A, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Schoenherr U, Mills D, Salgado LR, Biller BM, Pasireotide B2305 Study Group. A 12-month phase 3 study of pasireotide in Cushing's disease. N Engl J Med. 2012 Mar 8; 366 (10):914-24
    View PubMed
  73. Sathyanarayana P, Jogi M, Muthupillai R, Krishnamurthy R, Samson SL, Bajaj M. Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes. Obesity (Silver Spring). 2011 Dec; 19 (12):2310-5 Epub 2011 June 09
    View PubMed
  74. Samson SL, Sathyanarayana P, Jogi M, Gonzalez EV, Gutierrez A, Krishnamurthy R, Muthupillai R, Chan L, Bajaj M. Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial. Diabetologia. 2011 Dec; 54 (12):3093-100 Epub 2011 Sept 29
    View PubMed
  75. Katznelson L, Atkinson JL, Cook DM, Ezzat SZ, Hamrahian AH, Miller KK, American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly--2011 update. Endocr Pract. 2011 Jul-Aug; 17 Suppl 4:1-44.
    View PubMed
  76. Shahani S, Nudelman RJ, Nalini R, Kim HS, Samson SL. Ectopic corticotropin-releasing hormone (CRH) syndrome from metastatic small cell carcinoma: a case report and review of the literature. Diagn Pathol. 2010 Aug 31; 5:56
    View PubMed
  77. Yechoor V, Liu V, Paul A, Lee J, Buras E, Ozer K, Samson S, Chan L. Gene therapy with neurogenin 3 and betacellulin reverses major metabolic problems in insulin-deficient diabetic mice. Endocrinology. 2009 Nov; 150 (11):4863-73 Epub 2009 Oct 09
    View PubMed
  78. Samson SL, Kohjima M, Chan L. A fine balance: an autoregulatory gene therapy approach to treat obesity and achieve energy homeostasis. Gene Ther. 2009 Oct; 16(10):1175-7. Epub 2009 Jul 23.
    View PubMed
  79. Yang Y, Chang BH, Samson SL, Li MV, Chan L. The Kruppel-like zinc finger protein Glis3 directly and indirectly activates insulin gene transcription. Nucleic Acids Res. 2009 May; 37 (8):2529-38 Epub 2009 Mar 05
    View PubMed
  80. Samson SL, Gonzalez EV, Yechoor V, Bajaj M, Oka K, Chan L. Gene therapy for diabetes: metabolic effects of helper-dependent adenoviral exendin 4 expression in a diet-induced obesity mouse model. Mol Ther. 2008 Nov; 16 (11):1805-12 Epub 2008 Sept 09
    View PubMed
  81. Freedman RJ, Samson SL, Edwards AL, Schaefer JP, Southern DA, Quan H, Ghali WA. Glycemic control and use of the insulin sliding scale in hospitalized patients with diabetes. J Healthc Qual. 2007 Mar-Apr; 29 (2):31-7
    View PubMed
  82. Samson SL, Pownall HJ, Scott LW, Ballantyne CM, Smith EO, Sekhar RV, Balasubramanyam A. Heart positive: design of a randomized controlled clinical trial of intensive lifestyle intervention, niacin and fenofibrate for HIV lipodystrophy/dyslipidemia. Contemp Clin Trials. 2006 Dec; 27 (6):518-30 Epub 2006 July 21
    View PubMed
  83. Samson SL, Chan L. Gene therapy for diabetes: reinventing the islet. Trends Endocrinol Metab. 2006 Apr; 17 (3):92-100 Epub 2006 Feb 28
    View PubMed
  84. Samson SL, Wong NC. Role of Sp1 in insulin regulation of gene expression. J Mol Endocrinol. 2002 Dec; 29 (3):265-79
    View PubMed
  85. Samson SL, Paramchuk WJ, Gedamu L. The rainbow trout metallothionein-B gene promoter: contributions of distal promoter elements to metal and oxidant regulation. Biochim Biophys Acta. 2001 Jan 26; 1517 (2):202-11
    View PubMed
  86. Bittel D, Dalton T, Samson SL, Gedamu L, Andrews GK. The DNA binding activity of metal response element-binding transcription factor-1 is activated in vivo and in vitro by zinc, but not by other transition metals. J Biol Chem. 1998 Mar 20; 273 (12):7127-33
    View PubMed
  87. Samson SL, Gedamu L. Molecular analyses of metallothionein gene regulation. Prog Nucleic Acid Res Mol Biol. 1998; 59:257-88
    View PubMed
  88. Samson SL, Paramchuk WJ, Shworak NW, Gedamu L. Functional analyses of the human metallothionein-IG gene. In vitro and in vivo studies. J Biol Chem. 1995 Oct 20; 270 (42):25194-9
    View PubMed
  89. Samson SL, Gedamu L. Metal-responsive elements of the rainbow trout metallothionein-B gene function for basal and metal-induced activity. J Biol Chem. 1995 Mar 24; 270 (12):6864-71
    View PubMed
PST-20503959